Поиск
×
Поиск по сайту
Часть 36 из 49 В начало
Для доступа к библиотеке пройдите авторизацию
73 24. Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI. Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ 2012; 345: e4944. 74 25. Lopez LM, Ramesh S, Chen M, et al. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev 2016; (8): CD008815. 75 26. NICE. Clinical Knowledge Summary: Contraception – progestogen-only methods. 2017. https://cks.nice.org.uk/contraception-progestogen-only-methods. 76 27. Tyler KH, Zirwas MJ. Contraception and the dermatologist. J Am Acad Dermatol 2013; 68(6): 1022–9. 77 25. Lopez LM, Ramesh S, Chen M, et al. Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev 2016; (8): CD008815. 78 28. Lopez LM, Chen M, Mullins Long S, Curtis KM, Helmerhorst FM. Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database Syst Rev 2015; (7): CD009849. 79 29. Hidalgo M, Bahamondes L, Perrotti M, Diaz J, Dantas-Monteiro C, Petta C. Bleeding patterns and clinical performance of the levonorgestrel-releasing intrauterine system (Mirena) up to two years. Contraception 2002; 65(2): 129–32. 80 30. Lethaby A, Hussain M, Rishworth JR, Rees MC. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 2015; (4): CD002126. 81 31. Darney PD, Stuart GS, Thomas MA, Cwiak C, Olariu A, Creinin MD. Amenorrhea rates and predictors during 1 year of levonorgestrel 52 mg intrauterine system use. Contraception 2018; 97(3): 210–4. 82 32. Gemzell-Danielsson K, Schellschmidt I, Apter D. A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertil Steril 2012; 97(3): 616–22 e1-3. 83 33. Crosby RA, DiClemente RJ, Wingood GM, Lang D, Harrington KF. Value of consistent condom use: a study of sexually transmitted disease prevention among African American adolescent females. Am J Public Health 2003; 93(6): 901–2. 84 34. Andrade AT, Pizarro Orchard E. Quantitative studies on menstrual blood loss in IUD users. Contraception 1987; 36(1): 129–44. 85 35. Hubacher D, Chen PL, Park S. Side effects from the copper IUD: do they decrease over time? Contraception 2009; 79(5): 356–62.
book-ads2
Перейти к странице:
Подписывайся на Telegram канал. Будь вкурсе последних новинок!